Ultragenyx Pharma (RARE) Tops Q1 EPS by 8c
Ultragenyx Pharma (NASDAQ: RARE) reported Q1 EPS of ($1.63), $0.08 better than the analyst estimate of ($1.71).
For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.
Ultragenyx Pharma (NASDAQ: RARE) reported Q1 EPS of ($1.63), $0.08 better than the analyst estimate of ($1.71).
For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.